Identification of Small Molecule Inhibitors of a Mir155 Transcriptional Reporter in Th17 Cells

MicroRNA miR-155 is an important regulatory molecule in the immune system and is highly expressed and functional in Th17 cells, a subset of CD4 + T helper cells which are key players in autoimmune diseases. Small molecules that can modulate miR-155 may potentially provide new therapeutic avenues to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2021-06, Vol.11 (1), p.11498-11498, Article 11498
Hauptverfasser: Singh, Anju, Dashynam, Myagmarjav, Chim, Bryan, Escobar, Thelma M., Liu, Xiuhuai, Hu, Xin, Patnaik, Samarjit, Xu, Xin, Southall, Noel, Marugan, Juan, Jadhav, Ajit, Lazarevic, Vanja, Muljo, Stefan A., Ferrer, Marc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:MicroRNA miR-155 is an important regulatory molecule in the immune system and is highly expressed and functional in Th17 cells, a subset of CD4 + T helper cells which are key players in autoimmune diseases. Small molecules that can modulate miR-155 may potentially provide new therapeutic avenues to inhibit Th17 cell-mediated autoimmune diseases. Here, we present a novel high-throughput screening assay using primary T cells from genetically engineered Mir155 reporter mice, and its use to screen libraries of small molecules to identify novel modulators of Th17 cell function. We have discovered a chemical series of ( E )-1-(phenylsulfonyl)-2-styryl-1 H -benzo[ d ] imidazoles as novel down-regulators of Mir155 reporter and cytokine expression in Th17 cells. In addition, we found that FDA approved antiparasitic agents belonging to the ‘azole’ family also down-regulate Mir155 reporter and cytokine expression in Th17 cells, and thus could potentially be repurposed to treat Th17-driven immunopathologies.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-021-90944-7